Eargo weathers the storm – stays listed on US exchange
Hearing aid manufacturer Eargo has handed in its first report for 2022, which had reportedly been delayed due to a now-settled fraud case, and has been allowed to stay listed on the exchange in New York.
by albert rønning-andersson, translated by daniel pedersen
The list of firms publicly traded firm in the US will continue to include hearing aid manufacturer Eargo.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Eargo gets second warning from Nasdaq for missing reports
For subscribers
US senators propose bill to force finalization of OTC rules
For subscribers
